Interestingly, proteins belonging to signalling pathways not chosen to 'anchor' the analysis (such as IMD (= Immune Deficiency) and JNK (= Jun N-terminal kinase)) are classified within signalling modules defined by the 'anchoring' pathways (TGF1 and TOL2 for IMD, HH2 EGFR and TOR RAS2 for JNK). This evidence concerns the gene EGFR and Immunodeficiency.